EA
Euroapi S.A.
EAPI.PA · PAR
0.84 € -1.41% (-0.01 €)
1M -11.41%
Market Cap 82.0M €
P/E Ratio -
Div. Yield -
ROE 26.46%
Bulios Fair Price
0.53 €
37.1% downside
Current Price
0.84 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EAPI.PA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.10x
P/B 0.10x
P/FCF 1.74x
Growth
0 /100
Declining Book val. growth 10.80%
Rev. growth 4.73%
FCF growth N/A
Profitability
17 /100
Weak Net margin 24.90%
Op. margin 0.21%
FCF margin 5.54%
Quality
8 /100
Poor ROE 26.46%
ROA 16.19%
Asset turnover 0.65x
Debt
80 /100
Low Current ratio 2.60x
Int. coverage 0.15x
Net debt/EBITDA -0.34x
Stability
54 /100
Moderate Rev. volatility 7.36%
EPS volatility 660.47%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EAPI.PA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
David Seignolle
Employees
3,000
Headquarters
Paris
Upcoming events
09 MAR
Earnings
Upcoming earnings report